These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 37702886)

  • 1. Precision Nutrition and Cardiovascular Disease Risk Reduction: the Promise of High-Density Lipoproteins.
    Hong BV; Agus JK; Tang X; Zheng JJ; Romo EZ; Lei S; Zivkovic AM
    Curr Atheroscler Rep; 2023 Oct; 25(10):663-677. PubMed ID: 37702886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-density lipoprotein: our elusive friend.
    Asztalos BF; Niisuke K; Horvath KV
    Curr Opin Lipidol; 2019 Aug; 30(4):314-319. PubMed ID: 31145119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoprotein's vascular protective functions in metabolic and cardiovascular disease - could extracellular vesicles be at play?
    Beazer JD; Patanapirunhakit P; Gill JMR; Graham D; Karlsson H; Ljunggren S; Mulder MT; Freeman DJ
    Clin Sci (Lond); 2020 Nov; 134(22):2977-2986. PubMed ID: 33210708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol efflux capacity, macrophage reverse cholesterol transport and cardioprotective HDL.
    Hutchins PM; Heinecke JW
    Curr Opin Lipidol; 2015 Oct; 26(5):388-93. PubMed ID: 26270810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.
    Kones R
    Vasc Health Risk Manag; 2013; 9():617-70. PubMed ID: 24174878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) and diet-a challenge for a role of saturated fat in cardiovascular disease risk reduction?
    Law HG; Meyers FJ; Berglund L; Enkhmaa B
    Am J Clin Nutr; 2023 Jul; 118(1):23-26. PubMed ID: 37178716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (r)HDL in theranostics: how do we apply HDL's biology for precision medicine in atherosclerosis management?
    B Uribe K; Benito-Vicente A; Martin C; Blanco-Vaca F; Rotllan N
    Biomater Sci; 2021 May; 9(9):3185-3208. PubMed ID: 33949389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision Nutrition to Improve Risk Factors of Obesity and Type 2 Diabetes.
    Antwi J
    Curr Nutr Rep; 2023 Dec; 12(4):679-694. PubMed ID: 37610590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Where next with HDL assays?
    Niisuke K; Horvath KV; Asztalos BF
    Curr Opin Lipidol; 2018 Aug; 29(4):293-298. PubMed ID: 29846266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision Nutrition: A Review of Personalized Nutritional Approaches for the Prevention and Management of Metabolic Syndrome.
    de Toro-Martín J; Arsenault BJ; Després JP; Vohl MC
    Nutrients; 2017 Aug; 9(8):. PubMed ID: 28829397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic elevation of high-density lipoproteins: recent insights on mechanism of action and atherosclerosis protection.
    Meyers CD; Kashyap ML
    Curr Opin Cardiol; 2004 Jul; 19(4):366-73. PubMed ID: 15218398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics in Precision Nutrition.
    Li X; Qi L
    J Pers Med; 2022 Mar; 12(4):. PubMed ID: 35455649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to ditch HDL-C as a measure of HDL function?
    Ronsein GE; Heinecke JW
    Curr Opin Lipidol; 2017 Oct; 28(5):414-418. PubMed ID: 28777110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now?
    Diab A; Dastmalchi LN; Gulati M; Michos ED
    Vasc Health Risk Manag; 2023; 19():237-253. PubMed ID: 37113563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density lipoproteins: a consensus statement from the National Lipid Association.
    Toth PP; Barter PJ; Rosenson RS; Boden WE; Chapman MJ; Cuchel M; D'Agostino RB; Davidson MH; Davidson WS; Heinecke JW; Karas RH; Kontush A; Krauss RM; Miller M; Rader DJ
    J Clin Lipidol; 2013; 7(5):484-525. PubMed ID: 24079290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
    Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
    Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoprotein as a therapeutic target: a systematic review.
    Singh IM; Shishehbor MH; Ansell BJ
    JAMA; 2007 Aug; 298(7):786-98. PubMed ID: 17699012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of lipoprotein subclasses with risk of all-cause and cardiovascular disease mortality in individuals with type 2 diabetes: A prospective cohort study.
    Li R; Chen JX; Lu Q; Geng TT; Xia PF; Wang Y; Chen LK; Shan ZL; Pan A; Liu G
    Diabetes Obes Metab; 2023 Nov; 25(11):3259-3267. PubMed ID: 37492984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could Artificial Intelligence/Machine Learning and Inclusion of Diet-Gut Microbiome Interactions Improve Disease Risk Prediction? Case Study: Coronary Artery Disease.
    Vilne B; Ķibilds J; Siksna I; Lazda I; Valciņa O; Krūmiņa A
    Front Microbiol; 2022; 13():627892. PubMed ID: 35479632
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.